Tandem cycle high-dose chemotherapy (HDCT) of melphalan (MEL) and busulfan/cyclophosphamide (BU/CY) with peripheral blood progenitor cell rescue (PBPC) in multiple myeloma (MM).

被引:0
|
作者
Somlo, G [1 ]
Snyder, D [1 ]
Brown, A [1 ]
Dagis, A [1 ]
Nademanee, A [1 ]
ODonnell, M [1 ]
Parker, P [1 ]
Stein, A [1 ]
Smith, E [1 ]
Molina, A [1 ]
Spielberger, R [1 ]
Margolin, K [1 ]
Planas, I [1 ]
Kashyap, A [1 ]
Chow, W [1 ]
Fung, H [1 ]
Bhatia, R [1 ]
Forman, SJ [1 ]
机构
[1] CITY HOPE NATL MED CTR,DUARTE,CA 91010
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1709 / 1709
页数:1
相关论文
共 50 条
  • [21] A randomized comparison of total-marrow irradiation, Busulfan and cyclophosphamide with tandem high-dose melphalan in patients with multiple myeloma
    Knop, Stefan
    Bauer, Katja
    Hebart, Holger
    Wandt, Hannes
    Trumper, Lorenz
    Liebisch, Peter
    Maschmeyer, Georg
    Peest, Dietrich
    Wolf, Hans H.
    Kroger, Nikolaus
    Straka, Chrisian
    Pfreundschuh, Michael
    Coser, Paolo
    Meisner, Christoph
    Kanz, Lothar
    Einsele, Hermann
    BLOOD, 2007, 110 (11) : 223A - 224A
  • [22] MULTIPHASE THERAPY OF MULTIPLE-MYELOMA (MM) USING HIGH-DOSE BUSULFAN, MELPHALAN AND CYCLOPHOSPHAMIDE (BU+MEL+CY) FOLLOWED BY AUTOLOGOUS BONE-MARROW TRANSPLANTATION (AUBMT) WITH 4-HYDROPEROXYCYCLOPHOSPHAMIDE (4-HC) PURGING
    REECE, DE
    NANTEL, SH
    SUTHERLAND, HJ
    KLINGEMANN, HG
    BARNETT, MJ
    SHEPHERD, JD
    PHILLIPS, GL
    BLOOD, 1993, 82 (10) : A266 - A266
  • [23] Busulfan, melphalan and carfilzomib high-dose chemotherapy and autologous haematopoietic stem cell transplantation in multiple myeloma
    Hagen, Patrick
    Norton, Joseph
    Tsai, Stephanie
    Campo, Loredana
    Lee, Mary
    Gomez, Kayeromi
    Stiff, Patrick
    BRITISH JOURNAL OF HAEMATOLOGY, 2024, 204 (04) : 1422 - 1428
  • [24] Escalating doses of intravenous Busulfan (Bu) with a fixed dose of melphalan (Mel) as a preparative regimen for patients (pts) with multiple myeloma (MM) undergoing autologous peripheral blood stem cell transplantation (PBSCT).
    Callander, NS
    Freytes, CO
    Walsh, T
    Ochoa, L
    Tran, H
    Nguyen, J
    Primeaux, S
    BLOOD, 2003, 102 (11) : 703A - 703A
  • [25] High-dose therapy with peripheral blood progenitor cell transplantation in multiple myeloma
    Goldschmidt, H
    Hegenbart, U
    Wallmeier, M
    Hohaus, S
    Engenhart, R
    Wannenmacher, M
    Haas, R
    ANNALS OF ONCOLOGY, 1997, 8 (03) : 243 - 246
  • [26] Tandem High-Dose Chemotherapy with Autologous Stem Cell Rescue using Thiotepa/Cyclophosphamide and Busulfan/Melphalan Regimens in Two Cases of High-Risk Neuroblastoma
    Mizushima, Yoshitaka
    Mitani, Yuichi
    Oshima, Koichi
    Mori, Makiko
    Fukuoka, Kohei
    Arakawa, Yuki
    Kawashima, Hiroshi
    Nakazawa, Atsuko
    Koh, Katsuyoshi
    PEDIATRIC BLOOD & CANCER, 2021, 68
  • [27] High-dose melphalan with non-cryopreserved autologous peripheral blood progenitor cell rescue for patients with multiple myeloma: results of a single centre experience
    Sahin, B
    Paydas, S
    Kilic, NB
    Yavuz, S
    Disel, U
    Kara, IO
    BONE MARROW TRANSPLANTATION, 2003, 31 : S85 - S85
  • [28] High-dose busulfan and cyclophosphamide followed by autologous bone marrow transplantation and/or peripheral blood progenitor cell rescue for metastatic breast cancer
    Kalaycioglu, ME
    Lichtin, AE
    Andresen, SW
    Tuason, L
    Bolwell, BJ
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1995, 18 (06): : 491 - 494
  • [29] Peripheral blood stem cell (PBSC) high dose melphalan (MEL) for multiple myeloma (MM) patients 70 yrs or older.
    Badros, A
    Siegel, E
    Tricot, G
    Zangari, M
    Desikan, R
    Morris, C
    Toor, A
    Fassas, A
    Anaissie, E
    Barlogie, B
    BLOOD, 2000, 96 (11) : 419A - 419A
  • [30] Peripheral blood progenitor cell mobilization and autografting following high-dose therapy in patients with multiple myeloma (MM)
    Goldschmidt, H
    Haas, R
    Hegenbart, U
    Wallmeier, M
    Hohaus, S
    Wannenmacher, M
    Hunstein, W
    BLOOD, 1996, 88 (10) : 512 - 512